The pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single tablet EB613, multi-tablet EB613 and Forteo® reported for the first time as an oral presentation at ENDO 2026 ...
The first-in-human, randomized, blinded, parallel-group, placebo-controlled Phase 1 study enrolled healthy adult male volunteers and single ascending doses of MAR002 demonstrated a favorable safety ...
South Bend is turning to artificial intelligence to help identify residents who may need assistance before they reach a crisis point.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results